glp 1 alzheimer's 2024 🧐Will GLP-1RA drugs be the future of altzeimers treatement? 🧠There are multiple studies underway assessing the effectiveness of glp-1 class of medications in prevention and/or delay of dementia 🧠Alzheimer's makes up 60%-80% GLP-1 improves the supportive ability

The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss.

But that clearly isnt the goal for Lilly

However, medication alone is rarely the complete answer

The majority of T2D management is in primary care, where clinicians (medical, nursing and pharmacist staff) play an important role in addressing patient needs and achieving treatment goals